Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications | Page 17

TABLE OF CONTENTS 14 COMPANY PROFILES...............................................................................................................139 • (Overview, Financials, Products & Services, Strategy, & Developments)* • 14.1 INTRODUCTION.............................................................................................................................................................139 • 14.2 B. BRAUN MELSUNGEN AG...........................................................................................................................................143 • 14.3 BECTON, DICKINSON AND COMPANY..........................................................................................................................145 • 14.4 BIOCON LIMITED...........................................................................................................................................................148 • 14.5 BIODEL INC....................................................................................................................................................................151 • 14.6 ELI LILLY AND COMPANY..............................................................................................................................................152 • 14.7 JULPHAR (ALSO KNOWN AS GULF PHARMACEUTICAL INDUSTRIES)........................................................................158 • 14.8 NOVO NORDISK A/S......................................................................................................................................................160 • 14.9 SANOFI.............. .............................................................................................................................................................166 • 14.10 WOCKHARDT LIMITED..................................................................................................................................................170 • 14.11 YPSOMED AG................................................................................................................................................................172 • *Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies. 15 APPENDIX................................................................................................................................175 • 15.1 INSIGHTS OF INDUSTRY EXPERTS...............................................................................................................................175 • 15.2 DISCUSSION GUIDE......................................................................................................................................................176 • 15.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE..............................................................................................181 • 15.4 AVAILABLE CUSTOMIZATIONS......................................................................................................................................181 • 15.5 RELATED REPORTS........................................................................................................................................................182 • [email protected] www.marketsandmarkets.com 17